Q1 2025 Holdings
Filed 2025-05-15 | 31 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $188.3M | 4,472,840 | 13.9% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $131.6M | 1,855,000 | 9.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $92.0M | 4,675,000 | 6.8% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $82.2M | 1,150,000 | 6.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $78.0M | 2,325,000 | 5.7% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $64.4M | 1,950,000 | 4.7% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $64.0M | 2,185,000 | 4.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $62.3M | 1,650,000 | 4.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $61.5M | 2,561,782 | 4.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $58.1M | 3,200,000 | 4.3% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $56.1M | 1,745,000 | 4.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $53.3M | 8,892,816 | 3.9% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $48.5M | 3,600,000 | 3.6% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $47.3M | 3,978,907 | 3.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $34.0M | 2,367,578 | 2.5% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $32.1M | 1,988,084 | 2.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $30.0M | 1,911,433 | 2.2% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $26.5M | 4,525,000 | 2.0% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $21.6M | 5,825,000 | 1.6% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $18.0M | 500,000 | 1.3% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $16.9M | 5,384,616 | 1.2% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $14.6M | 1,419,714 | 1.1% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $11.7M | 5,344,432 | 0.9% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $11.2M | 2,000,000 | 0.8% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $10.8M | 290,000 | 0.8% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $10.8M | 925,000 | 0.8% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $8.8M | 950,000 | 0.7% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $7.7M | 750,000 | 0.6% |
| Celcuity Inc(CELC) | COM | 15102K100 | $7.0M | 695,650 | 0.5% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $3.9M | 1,575,000 | 0.3% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $3.9M | 483,000 | 0.3% |